Montelukast Sodium with Levocetirizine DihydrochlorideCLEARGY M TABLET

This bi-layered tablet is a combination of Montelukast, a leukotriene receptor antagonist, and Levocetirizine, a second-generation antihistamine. The formulation is used for the effective management of allergic rhinitis and related respiratory conditions. Bi-layered tablet technology facilitates the controlled and sequential release of Montelukast and Levocetirizine, ensures immediate antihistaminic action from Levocetirizine and prolonged
anti-inflammatory effects from Montelukast, delivering enhanced patient compliance and symptom control throughout the day and night.

• Dosage: Once Daily OR as directed by the Physician.
• Form: Tablet
• Indications:
  1. Seasonal Allergic Rhinitis
  2. Perennial Allergic Rhinitis
  3. Symptomatic relief from Chronic Urticaria
  4. Asthma
  5. Allergic rhinitis associated with bronchial asthma
• Composition: Montelukast Sodium 10mg + Levocetirizine Dihydrochloride 5mg
• Mode of Action: This bi-layered tablet delivers dual-pathway allergy control by combining rapid antihistaminic action with sustained anti-leukotriene activity. Levocetirizine, a potent H1 receptor antagonist, blocks histamine-mediated allergic responses with minimal sedation. Montelukast, a CysLT1 receptor antagonist, inhibits leukotriene-driven inflammation, bronchoconstriction, and mucus secretion.
  The bilayered technology ensures time-synchronized release, offering 24-hour relief from allergic rhinitis, and mild asthma with improved compliance and symptom control.
• Packaging:10*10’S
• Therapy Area: Anti-Allergic